MM
Marco Metra
Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, University of Parma, University of Chicago, University of Brescia
Research areas: Medicine · Cardiology and Cardiovascular Medicine · Heart Failure Treatment and Management · Cardiovascular Function and Risk Factors · Heart rate and cardiovascular health
Employment
-
Vita-Salute San Raffaele University Full Professor of Cardiology2025 - Present
-
IRCCS Ospedale San Raffaele Director2025 - Present
-
Università degli Studi di Brescia Full Professor of Cardiology2015 - 2025
-
Università degli Studi di Brescia Associate Professor of Cardiology2001 - 2015
-
Università degli Studi di Brescia Reseracher1985 - 2001
Education
-
Università degli Studi di Parma Fellowship in cardiology1985 - Present
-
University of Chicago Research associate1985 - 1985
-
Università degli Studi di Parma Fellowship in Internal Medicine? - 1989
-
Università degli Studi di Parma Medical Doctor? - 1981
Projects & Funding
Projects & funding information is unavailable.
Publications (1458)
- Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF Save
- Heart Failure Association Summit 2026: From Dialogue to Implementation: A Call to Further Improve Heart Failure Care Save
- Suture-mediated patent foramen ovale closure with the NobleStitch EL system: a systematic review and single-arm meta-analysis Save
- Early Sudden Cardiac Death Risk in Heart Failure: Time to Rethink Primary Prevention? Save
- Secondary mitral and tricuspid regurgitation in early HFrEF: the impact of contemporary medical therapy Save
- Effect of Omecamtiv Mecarbil According to PREDICT-HF Risk Score Save
- Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription Save
- Interaction between GRASP-HF and ICARe-HF: a strategic alliance to improve heart failure care in Europe and beyond Save
- Istaroxime’s Effect on Hemodynamics and Arrhythmias in Cardiogenic Shock Save
- Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction Save
- Dipstick proteinuria and outcomes in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF Save
- Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial Save
- Evidence-based medical therapy after structural interventions: when remaining proactive for heart failure medications can save lives Save
- Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction Save
- 2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation Save
- Priority measures for implementation: an ESC pilot linking guidelines to practice Save
- Liver disease in tricuspid regurgitation: from congestion to cirrhosis Save
- The multidimensional needs of chronic heart failure patients and caregivers from a dyadic perspective: a scoping review Save
- Effect of contemporary HFpEF therapies on diuretic management: decongestive role or disease modification? Save
- Attitudes towards using single-pill combination (polypill) therapy in heart failure: patients' and physicians' perspectives Save